Clinical trial
UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple…
NCT00113932 · University of Arkansas, Other · Completed
Key facts
| NCT number | NCT00113932 |
|---|---|
| Title | UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma |
| Official title | UARK 2003-41: A Phase II Study of High-Dose Density Therapy With Tandem Autologous Transplants for Patients With Multiple Myeloma |
| Lead sponsor | University of Arkansas, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Procedure |
| Interventions | High-Dose Density Therapy |
| Enrollment | 140 |
| Start date | Dec 1, 2003 |
| Primary completion | Feb 1, 2009 |
| Completion | Jul 1, 2010 |
| First posted | Jun 13, 2005 |
| Last update posted | Sep 2, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: